What Abacus Medicine does

Abacus Medicine Group is a privately-held Danish pharmaceutical services company founded in 2004 and headquartered in Copenhagen. The Group operates a multi-business-unit model built around European parallel distribution of prescription medicines — a regulated arbitrage model that sources pharmaceuticals from lower-price EU member states and re-distributes them to higher-price EU markets, exploiting legally permitted intra-EU price differentials. Beyond the core parallel-import business (Abacus Medicine, Originalis, Medigroup, and the newly acquired A.forall Retail & Hospital division), the Group operates a pharmaceutical wholesale business in the Benelux region through Pluripharm (including the Thuisapotheek certified online pharmacy), a commercialization-services arm for specialty and rare-disease medicines (Abacus Medicine Pharmaceuticals, formerly Aposave), and a clinical-trial comparator sourcing unit (Abacus Medicine Clinical Trial Services). Underlying operations include in-house repackaging facilities in Hungary (two Budapest sites) and Alkmaar (Netherlands), GDP-certified warehouses across Hungary, Netherlands, Belgium, and Ireland, and a Microsoft-supported data/analytics layer used for trading optimization.

The Group's revenue model combines transaction-based parallel trading and wholesale distribution with professional-services fees from its commercialization and clinical-trial units. Pricing is quote-based B2B; no public price list is disclosed. Customers include independent community pharmacies, outpatient and hospital pharmacies, hospital networks (including tender contracts), pharmaceutical and biotech manufacturers seeking European market entry, clinical-trial sponsors, and — via Thuisapotheek — patients in the Netherlands. Go-to-market is sales-led, organized by country and business unit, with Key Account and Market Access Managers in each territory and a stated presence in 14 countries (12 owned locations plus market coverage extending to 40+ supplied countries in 2025). In 2025, the Group recorded EUR 1,817.6 million in revenue (22% YoY growth) and employed 1,759 people across 56 legal entities.

Name

Abacus Medicine

Legal name

Abacus Medicine A/S

Website

https://abacusmedicinegroup.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Abacus Medicine Group is a Danish pharmaceutical services company founded in 2004 that distributes prescription medicines across Europe via parallel import, wholesale (Pluripharm), commercialization services (Abacus Medicine Pharmaceuticals), and clinical-trial comparator sourcing, serving pharmacies, hospitals, and pharma manufacturers in 40+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Parallel drug distribution
• Pharmaceutical wholesale
• Medicine importation
• Clinical trial sourcing
• Pharma commercialization

Headquarters

HQ city

Copenhagen

HQ country

Denmark

HQ region

Europe

Offices10 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharma Trading (Parallel Import): Core business model involving arbitrage trading based on price differences of prescription medicines across EU countries. Abacus Medicine imports medicine from EU countries with lower prices to sell in EU countries with higher prices at reduced costs. Includes operations through Abacus Medicine, Originalis, and acquired businesses like Medigroup.
2. Pharma Wholesale: Full-line pharmaceutical wholesaler operations through Pluripharm delivering medicines, medical devices and services to independent community pharmacies, outpatient and hospital pharmacies throughout the Netherlands. Also includes direct-to-patient services through certified online pharmacy Thuisapotheek.
3. Pharmaceuticals: End-to-end commercialization services for global pharma and biotech innovators launching products in the EU and UK, including market access, commercial execution, and distribution. Operated through Abacus Medicine Pharmaceuticals (AMP).
4. Clinical Trial Services: Comparator sourcing services provided through Abacus Medicine Clinical Trial Services to support pharma companies running clinical trials.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Abacus Medicine Group operates as a European parallel distributor of prescription medicines, sourcing products from lower-priced EU member states and re-selling them in higher-priced EU markets at reduced costs. The Group supplements this core arbitrage trading model with full-line pharmaceutical wholesale through Pluripharm in the Benelux region, end-to-end commercialization services for specialty and rare-disease medicines via Abacus Medicine Pharmaceuticals, comparator sourcing for clinical trials, and direct-to-patient online pharmacy operations (Thuisapotheek).

Product overview

Abacus Medicine Group operates as a multi-brand pharmaceutical services company with three main business divisions: Pharma Trading (parallel distribution), Pharmaceuticals, and Pharma Wholesale. The core product is Abacus Medicine, a market leader in European parallel distribution that imports prescription medicines from lower-price EU countries to sell at reduced prices in higher-price markets. The Group's portfolio includes Abacus Medicine Clinical Trial Services (comparator sourcing for clinical trials), Abacus Medicine Pharmaceuticals (commercialization services for specialty and rare disease medicines), Originalis (parallel distribution in Germany and Ireland), Pluripharm (wholesale and online pharmacy in the Netherlands), and EcoPharmaSupply (medicine shortage mitigation). The company generates value through arbitrage trading based on price differences across Europe, supported by logistics, trading data analytics, and a pan-European sourcing network.

Differentiator

Problem solved

Functional benefit

Brands

• Abacus Medicine: Market leader in European parallel distribution of medicine
• Abacus Medicine Clinical Trial Services
• Abacus Medicine Pharmaceuticals
• Originalis
• Pluripharm
• EcoPharmaSupply
• Thuisapotheek

Products and services

• Abacus Medicine (Parallel Distribution) Parallel distribution of prescription medicines across Europe, importing products from EU countries with lower prices to sell at reduced prices in higher-price EU markets. Serves pharmacies, hospitals, and wholesalers across more than 40 countries.
• Abacus Medicine Clinical Trial Services Comparator sourcing services to support pharmaceutical companies running clinical trials, providing specialised medicines required as comparators in clinical studies.
• Abacus Medicine Pharmaceuticals (AMP) End-to-end commercialization services for global pharma and biotech innovators launching specialty and rare disease medicines in the EU and UK, including market access, commercial execution, and distribution. Now includes rights to innovative cardioplegic solution acquired from Swiss Cardio Technologies.
• Originalis Parallel distributor of prescription medicines operating in Germany and Ireland, providing customers with more options for significant savings on prescription medicines.
• Pluripharm Leading pharmaceutical wholesaler in the Netherlands offering a full line of medicines, medical devices, and services to independent community pharmacies, outpatient pharmacies, and hospital pharmacies. Operates the Thuisapotheek online pharmacy.
• Thuisapotheek Online Pharmacy Certified online pharmacy operated by Pluripharm, specializing in fast and reliable home delivery of prescription medicines throughout the Netherlands, with special programs including Stop Smoking and Controlled Weight Loss.
• EcoPharmaSupply Service dedicated to mitigating medicine shortages by helping pharmacists find the medicines their patients need, regardless of product, price, or complexity.

Quantifiable outcome

• Revenue grew 23% to EUR 1,487 million in 2024, with 20 years of uninterrupted organic growth
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and supporting.

• MedigroupcoreStrategic or Co-development Partner · 1 January 2025Belgian parallel importer acquired in Pharma Trading division to strengthen market presence in Benelux region.
• EcoPharmaSupplysupportingStrategic or Co-development Partner · 1 January 2025Part of Abacus Medicine Group since 2025, contributing to strong position on European markets and ensuring high availability of medicines for hospitals and pharmacies.
• PluripharmcoreStrategic or Co-development Partner · 1 January 2020Acquired in 2020, Pluripharm is one of four leading pharmaceutical wholesalers in the Netherlands. Provides full-line wholesaler services and Thuisapotheek online pharmacy operations.
• Aposave (now Abacus Medicine Pharmaceuticals)coreStrategic or Co-development Partner · 1 January 2017Acquired in 2017 and rebranded as Abacus Medicine Pharmaceuticals. Originally provided pharma services, now provides end-to-end commercialization solutions for specialty medicines in Europe.
• A.forallcoreStrategic or Co-development PartnerAcquisition target for Retail and Hospital division. Belgian specialty pharma group (formerly Alter Pharma). Division is market leader in parallel importation in Belgium with approximately EUR 60 million revenue in 2024. Customer-facing brands include PI Pharma, Impexeco, and Eco.Pharma.Supply.
• Swiss Cardio TechnologiescoreStrategic or Co-development PartnerSwiss-based company acquired for innovative cardioplegic solution used in open heart surgery. Strengthened Abacus Medicine Pharmaceuticals market offering and marked shift from service provider to partnering-focused pharma organization.
• MicrosoftsupportingTechnology or IntegrationClose collaboration with Microsoft to optimize processes across the entire organization. As a highly data-driven business, the company leverages Microsoft technology for organizational optimization.
• Copenhagen Business School (CBS)supportingStrategic or Co-development PartnerOfficial Career Partner of Copenhagen Business School. Currently 40% of Student Analysts in Denmark are studying at CBS.

Scale indicators13 records

Recent moves3 records

Expansion highlights6 records

Broad incumbents

• Alliance Healthcare (Walgreens Boots Alliance): Major European pharmaceutical wholesaler and distributor serving pharmacies and hospitals. Comparable to Pluripharm's wholesale operations and Abacus's broader B2B pharma distribution model.
• PHOENIX Group: One of the largest pharmaceutical wholesalers in Europe, operating across 29 countries with parallel distribution and pre-wholesale activities. Comparable to Abacus's Pluripharm division and pan-European pharma distribution footprint.
• Cencora (formerly AmerisourceBergen): Global pharmaceutical solutions company providing distribution, consulting, and commercialization services. Comparable to the AMP division's commercialization services and Abacus's overall pharma distribution scale.
• McKesson Europe: European arm of McKesson, providing pharmaceutical distribution and wholesale services across multiple countries. Comparable as a broad-line pharma distributor with parallel distribution overlap.

Direct peers

• Orifarm: Denmark-based parallel distributor and pharmaceutical company with a similar business model of parallel import and branded generics across Europe. Direct head-to-head competitor in the European parallel trade market and a natural peer given shared Nordic origin.
• Mediq: European distributor of medical devices, pharmaceuticals, and related services to healthcare providers and patients. Comparable business model combining direct distribution with value-added services across European markets.

Regional players

• EBOS Group: Australasian pharmaceutical and medical device distribution company. Comparable as a large-scale pharmaceutical wholesaler with adjacent healthcare product lines, though primarily serving the APAC region.
• Tamro (part of PHOENIX Group): Finnish pharmaceutical wholesaler owned by PHOENIX Group, distributing pharmaceuticals and health products across the Nordics and Baltics. Comparable as a regional pharma wholesaler serving pharmacies and hospitals.

Emerging players

• Lexon (UK): UK-based pharmaceutical wholesale and parallel distribution company. Comparable as a specialist parallel importer/distributor operating in European markets with a similar niche positioning.
• Mawdsleys: UK pharmaceutical distribution and services company offering wholesale, clinical trial supply, and specialty pharma services. Comparable to Abacus's combination of distribution plus clinical trial services (AMP).

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/abacus-medicine-a-s
• Instagraminstagram.com/abacusmedicine
• Facebookfacebook.com/abacusmedicine

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abacus Medicine